S&P 500
7,757.17
+44.60
+0.58%
Dow
52,856.09
+360.19
+0.69%
Nasdaq
26,702.86
+278.04
+1.05%
NYSE Composite
24,253.12
+62.52
+0.26%
Russell 2000
2,781.02
+7.60
+0.27%
VIX
16.68
-0.63
-3.64%
CAH · Cardinal Health, Inc.
NEW YORK STOCK EXCHANGE, INC. - BOATS Real Time Price • USD
Cardinal Health Inc (CAH)
NEW YORK STOCK EXCHANGE, INC.
Health Care
$257.65
+0.15
(+0.06%)
● At close: October 21 at 4:00:00 PM EDT
$257.59
+0.13
(+0.05%)
Overnight:
10:02:44 PM EDT
DAY'S RANGE
$257.65
$255.94
$259.01
52-WEEK RANGE
$257.65
$152.46
$258.30
What's happening
- CAH is up 0.06% today, trading at $257.65. — Live quote
- It's trading within 3% of its 52-week high ($258.30). (Finnhub fundamentals)
- Volume today (100,776) is well below its 3-month average of 2,023,520. (Finnhub fundamentals)
- Reports earnings on 2026-11-05, 14 days away. (Finnhub earnings calendar)
- Last quarter's EPS beat estimates: $2.60 actual vs. $2.44 estimated (+6.4%). (Finnhub earnings history)
Deterministic template sentences filled in from the same sourced figures shown elsewhere on this page -- not an AI-written summary, no live model call.
Key Statistics
Analyst Recommendations
Strong buy 8
Buy 13
Hold 3
Sell 0
Strong sell 0
Aggregate ratings for 2026-09-01 (24 analysts polled by Finnhub) — consensus count.
Performance Overview (Trailing returns vs S&P 500 benchmark)
YTD RETURN
CAH
+23.63%
vs S&P 500
+11.70%
1-YEAR RETURN
CAH
+65.76%
vs S&P 500
+50.23%
6-MONTH RETURN
CAH
+18.19%
3-MONTH RETURN
CAH
+11.18%
Earnings Trends (Quarterly EPS Actual vs Estimate)
2026-07-26 (Q4 2026)
$2.60
Est. $2.44
BEAT +6.4%
2026-04-26 (Q3 2026)
$3.17
Est. $2.82
BEAT +12.6%
2026-01-26 (Q2 2026)
$2.63
Est. $2.40
BEAT +9.4%
2025-10-26 (Q1 2026)
$2.55
Est. $2.20
BEAT +15.9%
Valuation Measures & Ratios
Enterprise Value4$62.86B
Forward P/E517.27
PEG Ratio62.74
Price / Sales (TTM1)0.23
Price / Book714.54
EV4 / Revenue0.25
EV4 / EBITDA22.04
Profit Margin0.67%
Operating Margin0.98%
Return on Equity (ROE8)37.17%
Return on Assets (ROA9)3.02%
Avg Volume (3M)2,023,520
Quarterly history (5 periods)
| Measure | Dec '25 | Sep '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|
| Market cap | — | $37.08B | — | — | — |
| P/E | — | 20.93 | — | — | — |
| Price/Sales | — | 0.16 | — | — | — |
| Price/Book | — | -12.88 | — | — | — |
| EV/Revenue | — | 0.14 | — | — | — |
| EV/EBITDA | — | 9.23 | — | — | — |
| ROE | — | -61.55% | — | — | — |
| ROA | — | 3.21% | — | — | — |
Trailing-twelve-month ratios computed from SEC EDGAR quarterly figures and historical daily close prices (Alpaca). Diluted shares are derived from Net income ÷ EPS (diluted) for each quarter, not separately reported. Forward P/E/PEG unavailable (no free data source).
Glossary — what these abbreviations mean
- 1. TTM
- Trailing twelve months — the sum of the last four reported quarters, not a calendar year or the single latest quarter.
- 2. EPS
- Earnings per share — net income divided by diluted shares outstanding.
- 3. Beta
- A stock's historical volatility relative to the overall market. Above 1 means it has moved more than the market; below 1, less.
- 4. EV (Enterprise Value)
- Market cap plus total debt minus cash — roughly what it would cost to buy the whole company, debt included.
- 5. Forward P/E
- Price divided by analysts' estimated earnings for the next 12 months, instead of trailing actual earnings.
- 6. PEG Ratio
- P/E divided by expected earnings growth rate. A lower number can indicate a stock is cheap relative to how fast it's expected to grow.
- 7. Price / Book
- Share price divided by book value (assets minus liabilities) per share.
- 8. ROE
- Return on equity — net income divided by shareholders' equity, a measure of how efficiently a company turns equity into profit.
- 9. ROA
- Return on assets — net income divided by total assets, a measure of how efficiently a company turns assets into profit.
- 10. MRQ
- Most recent quarter — the single latest reported period, as opposed to TTM. The Financials section's "Quarterly" view below shows MRQ-style figures.
- 11. YoY
- Year over year — percent change versus the same period one year earlier, used for growth figures like those on Compare cards and the Screener.
Short Interest
Shares Short7,369,236
Change from Prior Settlement+10.50%
% of Float—
Days to Cover (Short Ratio)3.42
Source: FINRA Rule 4560 consolidated short interest, settlement date 2026-09-30. Reported bi-monthly with a reporting lag — not real-time.
Quotes and the 1-day extended-hours chart: Yahoo Finance. Longer historical charts: Alpaca (IEX feed) — real-time but IEX-only volume (~2.5% of consolidated market volume). Fundamentals + earnings: Finnhub.
Price history
Events
Drag horizontally to zoom into a section; use Reset view to restore all observations.
Technical signal summary
Calculating from the latest year of daily price history…
Show Technical Analysis Breakdown ▾ 10 Indicators
Not investment advice — read several signals together.
Indicators None active
Loading chart…
History limited by data provider; markers are heuristics, not signals.
Peer and sector context
No reviewed peer group is available for this symbol.
Balanced evidence
A deterministic summary of sourced facts—not an AI verdict.
Potential strengths
- Revenue growth is 5.8% on the provider's reported measure. Finnhub fundamentals ↗
- Trailing 52-week price return is +65.8%. Finnhub market metrics ↗
Potential concerns
- Net profit margin is 0.7%. Finnhub fundamentals ↗
- Latest SEC filing is Form 8-K, filed 2026-10-01; review it for current changes and risks. SEC EDGAR ↗
Rule-based facts only; absence from either side is not evidence, and this is not a recommendation.
More on CAH
No accessible free API for these — links go to the source directly.
Financials
Fundamental trends
Visualized from the same SEC figures in the tables below.
Income statement
| Line item | Dec '25 | Sep '25 | Mar '25 | Dec '24 | Sep '24 | Mar '24 | Dec '23 | Sep '23 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $65.63B | $64.01B | $54.88B | $55.26B | $52.28B | $54.87B | $57.44B | $54.65B |
| Gross profit | $2.40B | $2.32B | $2.12B | $1.94B | $1.90B | $1.94B | $1.85B | $1.74B |
| Operating income | $707.0M | $668.0M | $730.0M | $549.0M | $568.0M | $369.0M | $505.0M | -$32.0M |
| Net income | $467.0M | $450.0M | $506.0M | $400.0M | $416.0M | $261.0M | $368.0M | -$12.0M |
| EPS (diluted) | — | $1.88 | — | — | $1.70 | $1.07 | $1.50 | $-0.05 |
| EPS (basic) | — | $1.89 | — | — | $1.71 | $1.07 | $1.50 | $-0.05 |
| Operating margin | $1 | $1 | $1 | $1 | $1 | $1 | $1 | -$0 |
| Net margin | $1 | $1 | $1 | $1 | $1 | $0 | $1 | -$0 |
Balance sheet
| Line item | Jun '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $57.30B | $58.08B | $55.23B | $53.12B | $49.87B | $47.00B | $43.06B | $45.12B |
| Stockholders' equity | -$2.88B | -$2.88B | -$2.88B | -$2.78B | -$2.95B | -$2.99B | -$3.28B | -$3.21B |
| Total current assets | $38.75B | $39.23B | $38.54B | $36.37B | $34.59B | $35.76B | $32.91B | $34.88B |
| Total current liabilities | $43.90B | $43.31B | $40.27B | $38.90B | $36.66B | $35.22B | $34.68B | $35.64B |
| Cash & equivalents | $4.86B | $2.78B | $4.59B | $3.87B | $3.33B | $3.81B | $2.87B | $5.13B |
| Marketable securities (current) | — | — | — | — | — | — | — | $200.0M |
| Accounts receivable | $13.81B | $13.66B | $13.77B | $13.24B | $12.67B | $12.37B | $11.78B | $12.08B |
| Inventory | $17.30B | $20.12B | $17.56B | $16.83B | $16.16B | $16.90B | $15.62B | $14.96B |
| Other current assets | $2.76B | $2.67B | $2.60B | $2.41B | $2.40B | $2.62B | $2.59B | $2.66B |
| Property, plant & equipment | $3.03B | $2.88B | $2.83B | $2.86B | $2.66B | $2.56B | $2.54B | $2.53B |
| Goodwill | $11.44B | $11.61B | $9.71B | $9.69B | $8.91B | $5.49B | $4.72B | $4.72B |
| Intangible assets | $2.19B | $2.37B | $2.40B | $2.49B | $2.11B | $1.95B | $1.66B | $1.73B |
| Other non-current assets | $1.88B | $2.00B | $1.75B | $1.71B | $1.60B | $1.25B | $1.23B | $1.26B |
| Accounts payable | $38.28B | $39.00B | $36.86B | $34.71B | $32.81B | $31.30B | $30.36B | $31.76B |
| Short-term debt | — | — | — | — | — | — | — | — |
| Long-term debt | — | — | — | — | — | — | — | — |
| Common stock & paid-in capital | $2.89B | $2.85B | $2.75B | $2.96B | $2.95B | $2.93B | $2.83B | $2.92B |
| Retained earnings | $2.01B | $1.46B | $1.12B | $783.0M | $664.0M | $283.0M | $14.0M | -$286.0M |
| Accumulated other comprehensive income (loss) | -$165.0M | -$153.0M | -$159.0M | -$155.0M | -$176.0M | -$180.0M | -$155.0M | -$167.0M |
Cash flow
| Line item | Jun '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $3.52B | $686.0M | $973.0M | $1.53B | $2.91B | -$396.0M | -$1.65B | $2.08B |
| Investing cash flow | -$462.0M | -$1.98B | -$142.0M | -$1.63B | -$2.90B | -$976.0M | -$88.0M | $166.0M |
| Financing cash flow | -$973.0M | -$519.0M | -$110.0M | $656.0M | -$503.0M | $2.33B | -$540.0M | -$859.0M |
| Free cash flow | $3.10B | $555.0M | $865.0M | $1.29B | $2.79B | -$495.0M | -$1.74B | $1.89B |
| Capital expenditures | $410.0M | $131.0M | $108.0M | $232.0M | $126.0M | $99.0M | $90.0M | $193.0M |
| Depreciation & amortization | $723.0M | $234.0M | $233.0M | $209.0M | $399.0M | $192.0M | $182.0M | $186.0M |
| Share-based compensation | $187.0M | $87.0M | $93.0M | $153.0M | $31.0M | $30.0M | $30.0M | $33.0M |
| Deferred income taxes | $91.0M | — | — | $243.0M | — | — | — | -$104.0M |
| Change in inventory | -$2.79B | $2.54B | $736.0M | $607.0M | -$758.0M | $1.29B | $678.0M | -$2.37B |
| Change in accounts payable | -$713.0M | $2.03B | $2.15B | $1.78B | $1.42B | $924.0M | -$1.39B | -$294.0M |
| Purchases of investments | — | — | — | — | — | — | — | — |
| Sales/maturities of investments | — | — | — | — | — | — | — | — |
| Share repurchases | $600.0M | $383.0M | $375.0M | $0 | $375.0M | $15.0M | $375.0M | $0 |
| Debt issued | $0 | $0 | $1.00B | $0 | $0 | $2.90B | — | $0 |
| Debt repaid | $129.0M | $12.0M | $512.0M | $11.0M | $11.0M | $414.0M | $9.0M | $760.0M |
| Tax withholding on stock comp | — | — | — | — | — | — | — | — |
Income statement
| Line item | Jun '26 | Jun '25 | Jun '24 | Jun '23 | Jun '22 |
|---|---|---|---|---|---|
| Revenue | $254.25B | $222.58B | $226.83B | $204.98B | $181.33B |
| Gross profit | $9.77B | $8.17B | $7.41B | $6.87B | $6.48B |
| Operating income | $2.61B | $2.27B | $1.24B | $752.0M | -$607.0M |
| Net income | $1.71B | $1.56B | $852.0M | $330.0M | -$938.0M |
| EPS (diluted) | $7.23 | $6.45 | $3.45 | $1.26 | $-3.37 |
| EPS (basic) | $7.27 | $6.48 | $3.48 | $1.27 | $-3.37 |
| Operating margin | $1 | $1 | $1 | $0 | -$0 |
| Net margin | $1 | $1 | $0 | $0 | -$1 |
Balance sheet
| Line item | Jun '26 | Jun '25 | Jun '24 | Jun '23 | Jun '22 |
|---|---|---|---|---|---|
| Total assets | $57.30B | $53.12B | $45.12B | $43.35B | $43.88B |
| Stockholders' equity | -$2.88B | -$2.78B | -$3.21B | -$2.96B | -$709.0M |
| Total current assets | $38.75B | $36.37B | $34.88B | $33.74B | $32.94B |
| Total current liabilities | $43.90B | $38.90B | $35.64B | $33.74B | $30.55B |
| Cash & equivalents | $4.86B | $3.87B | $5.13B | $4.08B | $4.72B |
| Marketable securities (current) | — | — | $200.0M | — | — |
| Accounts receivable | $13.81B | $13.24B | $12.08B | $11.11B | $10.56B |
| Inventory | $17.30B | $16.83B | $14.96B | $16.12B | $15.64B |
| Other current assets | $2.76B | $2.41B | $2.66B | $2.29B | $2.02B |
| Property, plant & equipment | $3.03B | $2.86B | $2.53B | $2.46B | $2.36B |
| Goodwill | $11.44B | $9.69B | $4.72B | $4.61B | $5.86B |
| Intangible assets | $2.19B | $2.49B | $1.73B | $1.47B | $1.77B |
| Other non-current assets | $1.88B | $1.71B | $1.26B | $1.07B | $953.0M |
| Accounts payable | $38.28B | $34.71B | $31.76B | $29.93B | $27.13B |
| Short-term debt | — | — | — | — | — |
| Long-term debt | — | — | — | — | — |
| Common stock & paid-in capital | $2.89B | $2.96B | $2.92B | $2.75B | $2.81B |
| Retained earnings | $2.01B | $783.0M | -$286.0M | -$642.0M | -$280.0M |
| Accumulated other comprehensive income (loss) | -$165.0M | -$155.0M | -$167.0M | -$151.0M | -$114.0M |
Cash flow
| Line item | Jun '26 | Jun '25 | Jun '24 | Jun '23 | Jun '22 |
|---|---|---|---|---|---|
| Operating cash flow | $5.17B | $2.40B | $3.76B | $2.84B | $3.17B |
| Investing cash flow | -$2.58B | -$5.59B | -$1.85B | -$454.0M | $567.0M |
| Financing cash flow | -$1.60B | $1.94B | -$847.0M | -$3.05B | -$2.46B |
| Free cash flow | $4.53B | $1.85B | $3.25B | $2.36B | $2.79B |
| Capital expenditures | $649.0M | $547.0M | $511.0M | $481.0M | $387.0M |
| Depreciation & amortization | $956.0M | $790.0M | $710.0M | $692.0M | $692.0M |
| Share-based compensation | $367.0M | $244.0M | $121.0M | $96.0M | $81.0M |
| Deferred income taxes | $91.0M | $243.0M | -$104.0M | -$40.0M | $14.0M |
| Change in inventory | $488.0M | $1.82B | -$1.11B | $412.0M | $1.20B |
| Change in accounts payable | $3.46B | $2.73B | $1.82B | $2.82B | $3.56B |
| Sales/maturities of investments | — | — | — | — | — |
| Share repurchases | $1.36B | $765.0M | $750.0M | $2.00B | $1.00B |
| Debt issued | $1.00B | $2.90B | $1.14B | — | — |
| Debt repaid | $653.0M | $445.0M | $783.0M | $579.0M | $885.0M |
Source: SEC EDGAR XBRL filings (10-Q/10-K), as originally tagged by the company. Quarterly cash flow is reconstructed by de-cumulating fiscal-year-to-date figures (how cash flow is tagged in 10-Qs); other quarterly lines are reported directly.
Institutional holders
SEC Form 13F filers holding CAH as of the latest reported quarter. 13F only covers investment managers with $100M+ in assets — this is not a complete ownership picture, and does not include insiders (see Recent SEC filings below) or non-13F-eligible holders.
Source: Business Quant SEC Form 13F · report period 2026-06-30 · 30 filers
Held by These Filers60.3%
Shares Outstanding236,000,000
| Filer | Shares | Value | % Out | Qtr Change | Filed |
|---|---|---|---|---|---|
| BlackRock, Inc. | 26,490,633 | $6.29B | 11.22% | -7.0% | 2026-08-07 |
| VANGUARD CAPITAL MANAGEMENT LLC | 15,292,186 | $3.63B | 6.48% | +0.0% | 2026-06-30 |
| WELLINGTON MANAGEMENT GROUP LLP | 14,860,271 | $3.53B | 6.30% | +247.5% | 2026-08-14 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 13,717,894 | $3.26B | 5.81% | -0.1% | 2026-06-30 |
| State Street Corp | 11,967,121 | $2.84B | 5.07% | -0.9% | 2026-08-07 |
| GEODE CAPITAL MANAGEMENT, LLC | 6,472,810 | $1.53B | 2.74% | -1.6% | 2026-08-12 |
| Invesco Ltd. | 4,742,576 | $1.13B | 2.01% | +35.0% | 2026-08-13 |
| Morgan Stanley | 4,625,329 | $1.10B | 1.96% | -6.6% | 2026-08-11 |
| WCM INVESTMENT MANAGEMENT, LLC | 4,112,461 | $971.4M | 1.74% | +2.6% | 2026-08-13 |
| NORGES BANK | 3,726,422 | $885.2M | 1.58% | +0.0% | 2026-08-12 |
| Bank Of America Corp /De/ | 2,900,596 | $689.1M | 1.23% | +0.7% | 2026-08-14 |
| Northern Trust Corp | 2,868,903 | $681.5M | 1.22% | +2.7% | 2026-08-12 |
| Jpmorgan Chase & Co | 2,668,749 | $630.4M | 1.13% | +15.2% | 2026-08-12 |
| Goldman Sachs Group Inc | 2,385,033 | $566.6M | 1.01% | +0.6% | 2026-08-14 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 2,245,078 | $533.3K | 0.95% | +19.9% | 2026-08-14 |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 2,224,578 | $528.5M | 0.94% | -4.2% | 2026-08-13 |
| BNP PARIBAS FINANCIAL MARKETS | 2,103,149 | $499.6M | 0.89% | +39.8% | 2026-08-10 |
| FMR LLC | 2,066,248 | $490.9M | 0.88% | -51.3% | 2026-08-13 |
| VICTORY CAPITAL MANAGEMENT INC | 1,977,579 | $469.8M | 0.84% | +42.6% | 2026-08-07 |
| Legal & General Group Plc | 1,847,406 | $438.9M | 0.78% | -9.4% | 2026-08-14 |
| AQR CAPITAL MANAGEMENT LLC | 1,732,808 | $411.6M | 0.73% | +9.0% | 2026-08-14 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1,554,017 | $369.2M | 0.66% | -0.5% | 2026-08-14 |
| VANGUARD FIDUCIARY TRUST CO | 1,328,940 | $315.7M | 0.56% | -0.9% | 2026-06-30 |
| Ameriprise Financial Inc | 1,310,794 | $311.4M | 0.56% | -14.9% | 2026-08-14 |
| Bank of New York Mellon Corp | 1,299,209 | $308.6M | 0.55% | -4.4% | 2026-08-06 |
Insider activity
Directors, officers, and 10%+ owners' reported transactions from SEC Form 4. A filing reports a transaction; it does not by itself explain why it happened.
Insider activity is not available for this symbol right now.
Recent SEC filings
Official company reports and insider transaction filings. Form 4 reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR submissions · updated 2026-10-22 05:14 UTC
| Filed | Form | Report period | Official filing |
|---|---|---|---|
| 2026-10-01 | 8-K | 2026-10-01 | View on SEC.gov → |
| 2026-08-20 | 4 | 2026-08-19 | View on SEC.gov → |
| 2026-08-20 | 4 | 2026-08-18 | View on SEC.gov → |
| 2026-08-20 | 4 | 2026-08-18 | View on SEC.gov → |
| 2026-08-20 | 4 | 2026-08-18 | View on SEC.gov → |
| 2026-08-20 | 4 | 2026-08-18 | View on SEC.gov → |
| 2026-08-20 | 4 | 2026-08-18 | View on SEC.gov → |
| 2026-08-20 | 4 | 2026-08-18 | View on SEC.gov → |
| 2026-08-18 | 4 | 2026-08-15 | View on SEC.gov → |
| 2026-08-18 | 4 | 2026-08-15 | View on SEC.gov → |
| 2026-08-18 | 4 | 2026-08-15 | View on SEC.gov → |
| 2026-08-18 | 4 | 2026-08-15 | View on SEC.gov → |
Recent news
Headlines about CAH (Cardinal Health, Inc.). Links open the publisher — we don’t host full articles.
-
Cardinal Health, Inc. (CAH) Stock Price, News, Quote & History
Yahoo! Finance Canada · 2026-10-21 -
IBD Stock Of The Day Tests New Buy Point As Indicators Suggest More Upside
Yahoo Finance · 2026-10-21 -
Cardinal Health stock: Mizuho lifts target to USD 280.00 for Cardinal Health stock
AD HOC NEWS · 2026-10-21 -
Cardinal Health stock hits all-time high at 258.46 USD
Investing.com · 2026-10-21 -
Cardinal Health sets November 5 results date for Cardinal Health stock
AD HOC NEWS · 2026-10-21 -
Disposable Specimen Container Market Forecast Report 2026-2030 | Capitalize on Sterile Automation and $3.97B Demand with Leading Players Thermo Fisher, Cardinal Health, SARSTEDT and Greiner Bio-One
Yahoo Finance · 2026-10-21 -
Cardinal Health stock pre-market at EUR 230.20 on October 21
AD HOC NEWS · 2026-10-21 -
CAH Dec 2026 85.000 put (CAH261218P00085000) Stock Price, News, Quote & History
Yahoo! Finance Canada · 2026-10-21
No headlines in this category right now — try “All”.